Back
Sarepta Therapeutics Quote, Financials, Valuation and Earnings

Secure Your Family's Future in 15 Seconds With Gold-IRA
Take 15 Seconds to get the FREE Inflation Survival Plan and ensure your family's financial security.
Sell
47
SRPT
Sarepta Therapeutics
Last Price:
130.25
Seasonality Move:
15.81%
7 Day Trial
ALL ACCESS PASS
$
7

20-cent Gold Stock Has Backing of Major Gold Producers
The time to get in is now BEFORE next drill results are released.Sarepta Therapeutics Price Quote
$130.25
+0.06 (+1.46%)
(Updated: March 25, 2023 at 5:26 AM ET)
Sarepta Therapeutics Key Stats
Sell
47
Sarepta Therapeutics (SRPT)
is a Sell
Day range:
$126.99 - $130.54
52-week range:
$61.28 - $159.84
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
12.22
P/B ratio:
29.76%
Volume:
969.1K
Avg. volume:
1.8M
1-year change:
61.85%
Market cap:
$11.5B
Revenue:
$933M
EPS:
$-8.03
How Much Does Sarepta Therapeutics Make?
-
How Much Are Sarepta Therapeutics's Sales Annually?
SRPT Revenues are $933M -
How Much Profit Does Sarepta Therapeutics's Make A Year?
SRPT net income is -$703.5M
Is Sarepta Therapeutics Growing As A Company?
-
What Is Sarepta Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.28% -
What Is Sarepta Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Sarepta Therapeutics Stock Price Performance
-
Did Sarepta Therapeutics Stock Go Up Last Month?
Sarepta Therapeutics share price went up by 5.79% last month -
Did SRPT's Share Price Rise Over The Last Year?
SRPT share price rose by 61.85% over the past 1 year
What Is Sarepta Therapeutics 52-Week High & Low?
-
What Is Sarepta Therapeutics’s 52-Week High Share Price?
Sarepta Therapeutics has traded as high as $159.84 over the past 52 weeks -
What Is Sarepta Therapeutics’s 52-Week Low Share Price?
Sarepta Therapeutics has traded as low as $61.28 over the past 52 weeks
Sarepta Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Sarepta Therapeutics?
-
How Much Debt Does Sarepta Therapeutics Have?
Total long term debt quarterly is $1.5B -
How Much Cash Does Sarepta Therapeutics Have?
Cash and short term investments quarterly total is $2B -
What Is Sarepta Therapeutics’s Book Value Per Share?
Book value per share is 4.38
Is Sarepta Therapeutics Cash Flow Positive?
-
What Is SRPT Cash Flow From Operations?
Cash flow from operations (TTM) is -$325.3M -
What Is Sarepta Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $232.5M -
What Is Sarepta Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1B
Sarepta Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
SRPT return on invested capital is -36.22% -
What Is Sarepta Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -22.71% -
What Is SRPT Return On Equity?
ROE is a measure of profitability and is -105.72%
Sarepta Therapeutics Earnings Date & Stock Price
-
What Is Sarepta Therapeutics's Stock Price Today?
A single share of SRPT can be purchased today for 130.19 -
What Is Sarepta Therapeutics’s Stock Symbol?
Sarepta Therapeutics trades on the nasdaq under the ticker symbol: SRPT -
When Is Sarepta Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Sarepta Therapeutics is scheduled on May 4, 2023 -
When Is SRPT's next ex-dividend date?
Sarepta Therapeutics's next ex-dividend date is March 27, 2023 -
How To Buy Sarepta Therapeutics Stock?
You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Sarepta Therapeutics Competitors
-
Who Are Sarepta Therapeutics's Competitors?
Below is a list of companies who compete with Sarepta Therapeutics or are related in some way:
Sarepta Therapeutics Dividend Yield
Data Unavailable
Sarepta Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 40.57% |
Revenue: | 28.28% | 3.16% |
Analyst Recommendations
Buy Recommendations: | 11 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 170.42 |
Upside from Last Price: | 30.9% |